Tradestie Institutional Equity Comparison Engine

PTGX vs IONS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PTGX Overall Edge

PTGX Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Protagonist Therapeutics, Inc (PTGX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PTGX trades at 36.9x Forward P/E with 58.6% operating margin (+5723.6% YoY revenue) versus IONS at 90.9x Forward P/E and -58.8% operating margin (+54.9% YoY). In options structure, PTGX sits in CONSOLIDATION (3rd %ile IV; Dealer Gamma Walls on Pro) against IONS sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PTGX
PTGX 36.9x vs IONS 90.9x Fwd P/E
Growth & Margin Winner PTGX
Op Margin 58.6% vs -58.8% ยท YoY +5723.6% vs +54.9%
Momentum & Technical Winner PTGX
1Y +50.6% vs -59.1% ยท 52W Pos 58% vs 2%
Options & Structure Winner PTGX
CONSOLIDATION (3rd %ile IV) vs BREAKDOWN (17th %ile IV)
PTGX NASDAQ
Protagonist Therapeutics, Inc
Pharmaceutical Preparations
$125.40
-4.24% 1D
Market Cap $8.7B
1M Return -2.6%
1Y Return +50.65%
Forward P/E 36.9x
Unified AI Score
32.6 / 100 SELL
Tech 17.0 Fund 44.0 Flow 67.0 Mom 60.0
IONS NASDAQ
Ionis Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.57
-1.7% 1D
Market Cap $4.7B
1M Return -33.48%
1Y Return -59.1%
Forward P/E 90.9x
Unified AI Score
63.9 / 100 BUY
Tech 60.0 Fund 63.0 Flow 73.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PTGX +50.65% IONS -59.1% Spread: +109.75 pp (PTGX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PTGX Revenue IONS Revenue PTGX Op. Margin IONS Op. Margin Margin Edge
FY2018 $30M $600M -136.7% -10.2% IONS
FY2019 $0M $1.12B -34857.6% 32.6% IONS
FY2020 $30M $730M -225.4% -23.6% IONS
FY2021 $30M $810M -460.0% -3.7% IONS
FY2022 $30M $590M -494.2% -69.8% IONS
FY2023 $60M $790M -156.1% -44.9% IONS
FY2024 $430M $710M 58.2% -67.4% PTGX
FY2025 $50M $940M -343.6% -40.4% IONS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PTGX (9) vs IONS (1)
Institutional Metric PTGX IONS Criterion Row Winner
Market Capitalization Scale $8.7B $4.7B Larger Scale PTGX
Trailing P/E Ratio Valuation 28.1x 90.9x Lower Multiple PTGX
Forward P/E Ratio Valuation 36.9x 90.9x Lower Multiple PTGX
Revenue Growth (YoY) Growth +5723.6% +54.9% Higher Growth PTGX
Operating Margin (TTM) Profitability 58.6% -58.8% Higher Margin PTGX
Net Profit Margin Profitability 62.0% -56.9% Higher Margin PTGX
Return on Equity (ROE) Capital Efficiency 39.6% -108.0% Higher ROE PTGX
52-Week Range Position Momentum 58% ($77โ€“$161) 2% ($27โ€“$87) Stronger Trend PTGX
Beta / 30D Volatility Risk Regime 1.02ฮฒ ยท 35% Vol 0.18ฮฒ ยท 86% Vol Lower Realized Risk PTGX
Unified Institutional Score Composite Signal 32.6 / 100 (SELL) 63.9 / 100 (BUY) Higher Composite IONS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PTGX vs IONS Buy Guide
PTGX CONSOLIDATION
64d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live PTGX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IONS BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live IONS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PTGX nor IONS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.